Showing results (2551-2560 of 3,445) with videos related to

Sort By:
Pageof 345
Molecular Biology of the Cell|April 23, 2026
An E-cadherin endocytic mutant rescues the severe epidermal p120-catenin null phenotypeStephanie L Schell, Tadahiko Seo, Haifang Xu, et al.
The American Journal of Surgical Pathology|May 9, 2001
Translocation t(1;3)(p36.3;q25) is a nonrandom aberration in epithelioid hemangioendotheliomaM R Mendlick, M Nelson, D Pickering, et al.
JAMA Internal Medicine|June 29, 2026
Asynchronous Electronic Screening for Unhealthy Alcohol Use Among Veterans in Primary Care: A Cluster Randomized Quality Improvement TrialAshok Reddy, Karin M Nelson, John Geyer, et al.
AIDS Research and Human Retroviruses|January 16, 1998
A double-blind placebo-controlled phase II trial of thalidomide in asymptomatic HIV-positive patients: clinical tolerance and effect on activation markers and cytokinesJ B Marriott, S Cookson, E Carlin, et al.
Transplantation and Cellular Therapy|April 4, 2021
Anxiety and Depression Symptoms in Caregivers Prior to Hematopoietic Stem Cell Transplantation (HCT)Lauren P Waldman, Ashley M Nelson, Jamie M Jacobs, et al.
Neuroepidemiology|September 2, 2006
Effect of reproductive factors and postmenopausal hormone use on the risk of amyotrophic lateral sclerosisRita A Popat, Stephen K Van Den Eeden, Caroline M Tanner, et al.
Genome Biology and Evolution|June 28, 2019
Complete Genomes of Symbiotic Cyanobacteria Clarify the Evolution of Vanadium-NitrogenaseJessica M Nelson, Duncan A Hauser, José A Gudiño, et al.
The Journal of Thoracic and Cardiovascular Surgery|May 1, 1993
Plasma fentanyl levels in infants undergoing extracorporeal membrane oxygenationM P Leuschen, L D Willett, E B Hoie, et al.
The Journal of Antimicrobial Chemotherapy|February 16, 2010
Modelling response to HIV therapy without a genotype: an argument for viral load monitoring in resource-limited settingsA D Revell, D Wang, R Harrigan, et al.
Behavioural Pharmacology|November 9, 2007
Combined administration of subthreshold doses of the nitric oxide inhibitor, nitro-L-arginine, and muscarinic receptor antagonist, scopolamine, impairs complex maze learning in ratsPaul J Pistell, Lee W Daffin, Christopher M Nelson, et al.
Pageof 345